News Search Results

Displaying Results 326-350 of 4538 "biotechnology"

Mar 25, 2026, 19:01 ET WesternU College of Podiatric Medicine achieves 100% residency placement for 13 consecutive years

www.westernu.edu), located in Pomona, Calif. and Lebanon, Ore., is an independent nonprofit health professions university, conferring degrees in biotechnology and pharmaceutical sciences, dental medicine, medical sciences, nursing, optometry, osteopathic medicine, pharmacy,  physical therapy, physician

More news about: Western University of Health Sciences


Mar 25, 2026, 16:05 ET Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results

March 25, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat

More news about: Armata Pharmaceuticals, Inc.


Mar 25, 2026, 12:00 ET The Mark Foundation for Cancer Research Announces Global Expansion and $1M Funding Boost for Flagship Emerging Leader Award

tumors. In the eight years since the program was launched, recipients' work has already led to high-impact papers, clinical trials, and innovative biotechnology companies.For more information about the program, eligibility requirements, and application instructions, visit

More news about: The Mark Foundation for Cancer Research


Mar 25, 2026, 11:29 ET Rubin Rudman Adds Meredith Havard to Trusts & Estates and Fiduciary Litigation Groups

Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; hospitality companies; regulated industries, public entities and municipalities; insurance companies

More news about: Rubin Rudman


Mar 25, 2026, 10:45 ET Veterinary Diagnostics Market Size Worth USD 19.63 Billion by 2032, Exclusive Report by Maximize Market Research

Agrolabo S.p.A. (Italy)Asia-Pacific17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)18. Shenzhen Bioeasy Biotechnology Co. Ltd. (China)19. BioNote Inc. (South Korea)20. FUJIFILM Holdings Corporation (Japan)21. IM3Vet Pty Ltd. (Australia)Get

More news about: Maximize Market Research Pvt. Ltd.


Mar 25, 2026, 09:14 ET SOCMA Sees Strong Membership Growth with 13 New Members in Q1 2026

Contract Research, Development, and Manufacturing Organization committed to delivering innovative solutions for clients in the pharmaceutical, biotechnology, and other industries. Laxai "saw value in SOCMA as the premier organization in North America providing technical, operational, regulatory and commercial

More news about: Society of Chemical Manufacturers & Affiliates


Mar 25, 2026, 09:00 ET Frost & Sullivan: Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition for Excellence in Platform-Driven Biological Innovation

remains central to Locus FS's approach. Through precision microbial design and high-performing glycolipid biosurfactants, the company leverages biotechnology to develop biological alternatives that address complex operational, agronomic, and formulation challenges. Its unified, platform-driven process

More news about: Frost & Sullivan


Mar 25, 2026, 09:00 ET Frost & Sullivan: Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition for Excellence in Platform-Driven Biological Innovation

remains central to Locus FS's approach. Through precision microbial design and high-performing glycolipid biosurfactants, the company leverages biotechnology to develop biological alternatives that address complex operational, agronomic, and formulation challenges. Its unified, platform-driven process

More news about: Frost & Sullivan


Mar 25, 2026, 09:00 ET Merlin CP-GEP™ Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma

www.merlinmelanomatest.com.About SkylineDxSkylineDx is a biotechnology company focused on research and development of molecular diagnostics in oncology, and inflammatory and infectious diseases. SkylineDx uses its expertise

More news about: SkylineDx


Mar 25, 2026, 08:30 ET PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors

Managing Director and Chair of Biotechnology Investment Banking of Morgan Stanley after a distinguished career spanning over 40 years. She helped build the biotechnology banking practice at Morgan Stanley and is widely considered a pioneer in establishing the field of biotechnology investment banking. During

More news about: PTC Therapeutics, Inc.


Mar 25, 2026, 08:29 ET Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets

products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position

More news about: Lupin Pharmaceuticals, Inc.


Mar 25, 2026, 08:20 ET Cresilon Named One of the World's 50 Most Innovative Companies by Fast Company

fastcompany.com. It will also appear on newsstands beginning March 31, 2026.About CresilonCresilon® is a Brooklyn-based biotechnology company that develops, manufactures, and markets hemostatic medical devices using its proprietary hydrogel technology. The company's plant-based

More news about: Cresilon


Mar 25, 2026, 08:00 ET Kalohexis Announces Publication in Frontiers in Endocrinology Defining Design Criteria for Next-Generation Melanocortin Drugs for General Obesity

NORTHBROOK, Ill., March 25, 2026 /PRNewswire/ -- Kalohexis, a clinical-stage biotechnology company harnessing the melanocortin system to shape the next era of metabolic disease care starting with obesity and cancer cachexia, today announced

More news about: Kalohexis


Mar 25, 2026, 08:00 ET Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics

receive royalties based on net sales.Under the agreement, Biogen also holds an option to develop a third product."Biogen is a global biotechnology company leading innovation with strong research and development capabilities. We are very pleased to enter into this partnership and look forward

More news about: Alteogen Inc.


Mar 25, 2026, 08:00 ET VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial

GOTHENBURG, Sweden, March 25, 2026 /PRNewswire/ -- VERIGRAFT, a Swedish clinical-stage biotechnology company pioneering personalized, fully biological therapies, today announced the initiation of a pivotal Phase II/III trial of its P-TEV (personalized

More news about: VERIGRAFT


Mar 25, 2026, 06:05 ET MGI Tech Brings High-Throughput T7+ Sequencer to European Market at Analytica 2026 Debut

focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various

More news about: MGI Tech Co., Ltd.


Mar 25, 2026, 06:00 ET HanchorBio Advances Toward TWSE Innovation Board Listing to Accelerate Global Clinical Development, Platform Expansion, and International Partnering

SAN FRANCISCO, March 25, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation multifunctional biologics across oncology and immune-related diseases, today announced that it has received approval

More news about: HanchorBio Inc.


Mar 25, 2026, 06:00 ET Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results and Declares a Cash Dividend

clinical trial solution income represents the service income earned from our customers mainly including biopharmaceutical companies and leading biotechnology companies. We match qualified and suitable patients for enrollment in clinical trials for our customers and generate digital clinical trial solution

More news about: Waterdrop Inc.


Mar 25, 2026, 05:38 ET MirZyme Appoints Lindsey Carnett as U.S. Global Ambassador for Women's Health Innovation

MirZyme Therapeutics, a UK-based biotechnology company focused on transforming maternal health, today announced the appointment of

More news about: MirZyme Therapeutics Ltd.


Mar 25, 2026, 05:00 ET Complement Therapeutics Announces First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study for Geographic Atrophy Secondary to AMD

MUNICH, March 25, 2026 /PRNewswire/ -- Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the first patient has been dosed in Opti-GAIN,

More news about: Complement


Mar 25, 2026, 03:24 ET Peptide Therapeutics Market Growing at 7.16% CAGR to Reach USD 70.20 Bn by 2031 Driven by Rising Cancer Prevalence & Metabolic Disorder Burden, Reports Mordor Intelligence

Therapeutics Market Competitive Outlook The peptide therapeutics market features a mix of global pharmaceutical companies and specialized biotechnology firms focusing on innovation, pipeline expansion, and strategic collaborations. Market participants are investing in advanced peptide platforms,

More news about: Mordor Intelligence Private Limited


Mar 24, 2026, 19:50 ET Clover Announces Additional Positive U.S. Phase I Clinical Data for RSV Re-Vaccination in Older Adults

Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world, today announced additional positive

More news about: Clover Biopharma


Mar 24, 2026, 19:17 ET uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed; April 13, 2026, Lead Plaintiff Deadline

(short video)UNIQURE N.V. CLASS ACTION LAWSUIT - COMPLAINT ALLEGATION SUMMARY:uniQure is a biotechnology company developing gene therapies for rare diseases, including Huntington's disease (HD). uniQure's leading drug candidate is AMT-130, a novel gene

More news about: Kessler Topaz Meltzer & Check, LLP


Mar 24, 2026, 16:04 ET WesternU COMP-Northwest Class of 2026 celebrates successful Match Day

Oregon and Pomona, Calif., is an independent nonprofit health professions university, conferring degrees in osteopathic medicine, physical therapy, biotechnology and pharmaceutical sciences, dental medicine, medical sciences, nursing, optometry, pharmacy, physician assistant studies, podiatric medicine, and

More news about: Western University of Health Sciences (WesternU)


Mar 24, 2026, 15:05 ET NABR CONDEMNS ALLEGED BREAK-IN AND THEFT AT MIDWEST RESEARCH AND BREEDING FACILITY

research, education, and testing. Members include more than 340 universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology companies, patient groups, and academic and professional societies who rely on humane and responsible animal research to advance global human and

More news about: National Association for Biomedical Research


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.